JP2025511940A5 - - Google Patents

Info

Publication number
JP2025511940A5
JP2025511940A5 JP2024559584A JP2024559584A JP2025511940A5 JP 2025511940 A5 JP2025511940 A5 JP 2025511940A5 JP 2024559584 A JP2024559584 A JP 2024559584A JP 2024559584 A JP2024559584 A JP 2024559584A JP 2025511940 A5 JP2025511940 A5 JP 2025511940A5
Authority
JP
Japan
Application number
JP2024559584A
Other languages
Japanese (ja)
Other versions
JP2025511940A (ja
JPWO2023194584A5 (https=
Filing date
Publication date
Priority claimed from GBGB2205200.5A external-priority patent/GB202205200D0/en
Application filed filed Critical
Publication of JP2025511940A publication Critical patent/JP2025511940A/ja
Publication of JP2025511940A5 publication Critical patent/JP2025511940A5/ja
Publication of JPWO2023194584A5 publication Critical patent/JPWO2023194584A5/ja
Pending legal-status Critical Current

Links

JP2024559584A 2022-04-08 2023-04-06 グレムリン-1アンタゴニストとシチジン類似体又はデオキシシチジン類似体の組み合わせ Pending JP2025511940A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2205200.5A GB202205200D0 (en) 2022-04-08 2022-04-08 Combination with chemotherapy
GB2205200.5 2022-04-08
PCT/EP2023/059271 WO2023194584A1 (en) 2022-04-08 2023-04-06 Combination of a gremlin-1 antagonist with a cytidine analogue or deoxycytidine analogue

Publications (3)

Publication Number Publication Date
JP2025511940A JP2025511940A (ja) 2025-04-16
JP2025511940A5 true JP2025511940A5 (https=) 2026-04-14
JPWO2023194584A5 JPWO2023194584A5 (https=) 2026-04-14

Family

ID=81653327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024559584A Pending JP2025511940A (ja) 2022-04-08 2023-04-06 グレムリン-1アンタゴニストとシチジン類似体又はデオキシシチジン類似体の組み合わせ

Country Status (11)

Country Link
US (1) US20250243267A1 (https=)
EP (1) EP4504778A1 (https=)
JP (1) JP2025511940A (https=)
KR (1) KR20250004732A (https=)
CN (1) CN119343372A (https=)
AU (1) AU2023251209A1 (https=)
CA (1) CA3255381A1 (https=)
GB (1) GB202205200D0 (https=)
IL (1) IL315762A (https=)
MX (1) MX2024012464A (https=)
WO (1) WO2023194584A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117965736A (zh) * 2024-02-05 2024-05-03 南京医科大学康达学院 Grem1作为预测非小细胞肺癌转移或不良预后的生物标志物及其应用
CN117801109B (zh) * 2024-03-01 2024-05-03 再少年(北京)生物科技有限公司 iPS诱导定向分化成内皮祖细胞的方法及应用
WO2026027660A1 (en) 2024-08-02 2026-02-05 UCB Biopharma SRL Formulations of anti-gremlin-1 antibodies

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
WO1991010737A1 (en) 1990-01-11 1991-07-25 Molecular Affinities Corporation Production of antibodies using gene libraries
EP1690934A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0542810A1 (en) 1990-08-02 1993-05-26 B.R. Centre Limited Methods for the production of proteins with a desired function
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
CA2405246A1 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with alterred binding properties
DK0580737T3 (da) 1991-04-10 2004-11-01 Scripps Research Inst Heterodimere receptorbiblioteker ved anvendelse af phagemider
GB9113120D0 (en) 1991-06-18 1991-08-07 Kodak Ltd Photographic processing apparatus
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
EP0733070A1 (en) 1993-12-08 1996-09-25 Genzyme Corporation Process for generating specific antibodies
PT1231268E (pt) 1994-01-31 2005-11-30 Univ Boston Bancos de anticorpos policlonais
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
US7993864B2 (en) 2002-12-03 2011-08-09 Ucb Pharma S.A. Assay for identifying antibody producing cells
GB0312481D0 (en) 2003-05-30 2003-07-09 Celltech R&D Ltd Antibodies
ES2551439T5 (es) 2003-07-01 2018-11-08 Ucb Biopharma Sprl Fragmentos Fab de anticuerpos modificados
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0411186D0 (en) 2004-05-19 2004-06-23 Celltech R&D Ltd Biological products
US8383349B2 (en) * 2007-03-16 2013-02-26 The Board Of Trustees Of The Leland Stanford Junior University Bone morphogenetic protein antagonist and uses thereof
WO2009040562A1 (en) 2007-09-26 2009-04-02 Ucb Pharma S.A. Dual specificity antibody fusions
JP6339063B2 (ja) * 2012-03-15 2018-06-06 エスエヌユー アールアンドディービー ファウンデーション グレムリン−1に対する抗体
ES2898620T3 (es) 2013-03-14 2022-03-08 Regeneron Pharma Anticuerpos humanos contra GREM 1
WO2017158396A1 (en) * 2016-03-16 2017-09-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Cytidine deaminase inhibitors for the treatment of pancreatic cancer
GB201621635D0 (en) 2016-12-19 2017-02-01 Ucb Biopharma Sprl Crystal structure
PL3806898T3 (pl) 2018-06-18 2026-02-23 UCB Biopharma SRL Antagonista gremlin-1 do zastosowania w leczeniu nowotworu
JP2024504124A (ja) * 2021-01-18 2024-01-30 スーチョウ・トランスセンタ・セラピューティクス・カンパニー・リミテッド 新規の抗グレムリン1抗体

Similar Documents

Publication Publication Date Title
JP2025511940A5 (https=)
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13159U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13135U (https=)